Table 1.
Reference | Year | Age | Disease | Diagnostic tool | Sites of EMH |
Our case report | 2020 | 40 | β-TI pre-existing | Transvaginal US | Vertebral bodies, lungs and ovary |
Gadomski et al9 | 2017 | 31 | CML pre-existing | CT scan, abdominal and transvaginal US | Ovaries |
Palatnik et al10 | 2012 | 43 | CML newly diagnosed | CT scan (suspicious of pyosalpinges) | Uterus, tubes and ovaries |
Rabischong et al11 | 2010 | 50 | MF pre-existing | CT scan | Ovaries, tubes and lungs |
Khen-Dunlop et al12 | 2006 | 15 | β-TI pre-existing | US (suspicious of dermoid cyst at the beginning) and CT scan (suspicious of EMH) | Ovary and vertrebral bodies |
Eapen et al (Abstract)3 |
2004 | 43 | CML newly diagnosed | CT scan (suspicious of pyosalpinges or tubo-ovarian abscesses) |
Ovary |
Inoue et al13 | 1998 | 2 | Granulocytic sarcoma/newly diagnosed MML after spontaneous remission of MF | CT scan | Ovaries and paraaortic |
Hillman et al14 | 1968 | 2 | MF newly diagnosed | Autopsy | Ovary, spleen, liver and bones |
Lieberman et al15 | 1965 | 37 | MF on pre-existing regional enteritis and essential thrombocythaemia | Autopsy | Ovary, spleen, liver, scalp, small intestine, lungs, lymph nodes and spine |
CML, chronic myeloid leukaemia; CT scan, computerized tomography scan; EMH, extramedullary haematopoiesis; MF, myelofibrosis; MML, myelomonocytic leukaemia; US, ultrasound; β-TI, β-thalassaemia intermedia.